GL1X · GenesisL1 explorer

Research workbench

Lovastatin polyketide enoyl reductase (lovc) complexed with 2'- phosphoadenosyl isomer of crotonoyl-CoA

Analyse Lovastatin polyketide enoyl reductase (lovc) complexed with 2'- phosphoadenosyl… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3B6Z
Type
protein
Length
352 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl reductase
UniProt
Q9Y7D0
Ligands
CO7
Pockets
2 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 29% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnoyl reductaseprotein35229% helix, 24% strandQ9Y7D0

Ligands and binding sites

  • CO7 · S-{(9R,13R,15S)-17-[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)tetrahydrofuran-2-yl]-9,13,15-trihydroxy-10,10-dimethyl-13,15-dioxido-4,8-dioxo-12,14,16-trioxa-3,7-diaza-13,15-diphosphaheptadec-1-yl}(2E)-but-2-enethioate · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16710.790.8360CO7
21110.360.7314empty

Compared structures

  • 3B6Z · Lovastatin polyketide enoyl reductase (LovC) complexed with 2'-phosphoadenosyl isomer of… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9Y7D0 · AlphaFold monomer V2.0 prediction for lovastatin nonaketide synthase, enoyl reductase… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.